Centre for Epidemiological Modelling and Analysis (CEMA), have released results of three studies that could significantly ...

KUCHING: Asean must work together to reduce the cost of next-generation antiretroviral (ARV) drugs for HIV patients in their respective countries, says Datuk Lukanisman Awang Sauni.

KUCHING: Asean member states must work together to reduce the cost of next-generation antiretroviral (ARV) drugs for HIV ...

Findings from Kenya by CEMA at the International AIDS Society Conference on HIV ScienceRwanda, July 15, 2025-- The University of Nairobi, Center for Epidemiological Modelling and Analysis (CEMA), has ...

Experts have proposed new treatment modes for older people with HIV. The new treatment does not cause the health-threatening ...

Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, ...

ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with ...

An investigational once-weekly oral antiretroviral therapy (ART) combination effectively maintained viral suppression in ...

In a phase 2 trial, an antiretroviral combination developed by Gilead Sciences and MSD suppressed HIV with a single weekly oral dose, raising the hope of a new treatment option for patients. The ...

Using mRNA to stop HIV from hiding away in white blood cells could be the key to developing a way to eradicate the infection, rather than simply managing viral levels in the body. The tantalising ...